Home/Filings/4/0001127602-17-030206
4//SEC Filing

Gary M. Huff 4

Accession 0001127602-17-030206

CIK 0000920148other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 4:10 PM ET

Size

8.9 KB

Accession

0001127602-17-030206

Insider Transaction Report

Form 4
Period: 2017-09-01
Gary M. Huff
CEO, LabCorp Diagnostics
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2017-09-0115314,037 total
    Common Stock (153 underlying)
  • Exercise/Conversion

    Common Stock

    2017-09-01+153400.365 total
  • Tax Payment

    Common Stock

    2017-09-01$157.61/sh51$8,038349.365 total
Footnotes (5)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
  • [F2]Amount includes 193.3653 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
  • [F3]Stock withholding to satisfy tax withholding obligations.
  • [F4]The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17.
  • [F5]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Issuer

LABORATORY CORP OF AMERICA HOLDINGS

CIK 0000920148

Entity typeother
IncorporatedNC

Related Parties

1
  • filerCIK 0001702387

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 4:10 PM ET
Size
8.9 KB